🇺🇸 FDA
Patent

US 10441579

4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds

granted A61KA61K31/4465A61P

Quick answer

US patent 10441579 (4-[2-(2-fluorophenoxymethyl)phenyl]piperidine compounds) held by Theravance Biopharma R&D IP, LLC expires Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Theravance Biopharma R&D IP, LLC
Grant date
Tue Oct 15 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Oct 10 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
9
CPC classes
A61K, A61K31/4465, A61P, A61P11/06, A61P13/00